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ABSTRACT

Salmonella has been a major source of concern in public health and food industry. It is
the cause of gastrointestinal illness and fever called salmonellosis. Severe cases of salmonellosis
have resulted in hospitalization and even death around the world. Salmonella can be found in the
intestinal tract of animals including chickens and can be transmitted to human through
contaminated food. Hence, it is highly important to find ways of reducing the transmission of
Salmonella from chickens to humans. This work is focused on the control of Salmonella in
broiler chicken through the development of novel vaccine adjuvant. Two different aptamer
rolling circle amplification (RCA) products were developed and combined to produce the
vaccine complex: CD40-specific and Salmonella-specific RCA. CD40-specific RCA (termed
aptamer RCA II), presenting two CD40-specific aptamers, has the ability to boost immune
responses in broiler chickens through activation of the macrophage, and Salmonella-specific
RCA (termed 3Sal-aptamer RCA) presents 3 Salmonella-specific aptamers, displaying strong
binding affinity against various Salmonella serotypes, including S. Typhimurium, S. Enteritis and
S. Kentucky. These two RCA products (aptamer RCA II and 3Sal-aptamer RCA) were designed
to contain the spacer regions complementary to each other to facilitate the binding of the two
RCA products through hybridization of the spacer regions. The vaccine complex was formed in
the following steps: (1) 3Sal-aptamer RCA was incubated with S. Typhimurium cells, and
unbound S. Typhimurium cells were removed by extensive washing. (2) The 3Sal-aptamer RCAS. Typhimurium complex was then incubated with aptamer RCA II to form the final Salmonella
vaccine complex. We determined that on average 2.15 × 106 CFUs of S. Typhimurium cells
were loaded in 1 ml of RCA complex. These results showed that the final complex that consists

of 3 components of Salmonella-specific RCA, Salmonella cells, and CD40-specific RCA can be
a novel vaccine complex targeting CD40 for efficient control of Salmonella in broiler chickens.
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INTRODUCTION
Chicken meat contaminated with Salmonella continues to be a critical food safety issue
and salmonellosis is still a major source of concern when it comes to foodborne illness(Silva et
al., 2014). According to Center for Disease and Control (CDC), an estimate of 1.35 million
illnesses , 26,000 hospitalizations and 420 deaths per year in the United States is associated to
salmonellosis in humans (Silva et al., 2014). The most common serovars associated with
salmonellosis are Salmonella enterica serotype Typhimurium (S. Typhimurium) and Enteriditis
(S. Enteritidis). However, a subset of outbreaks has been attributed to 30 other serovars (Silva et
al., 2014). S. Typhimurium is linked with contamination in a variety of meat sources (beef, pork,
and poultry) and causes more human cases of foodborne illness, while S. Enteriditis is primarily
associated with poultry products, both poultry meat (Antunes et al., 2016; Chousalkar & Gole,
2016) and egg (Chousalkar et al., 2018). As this foodborne bacterial pathogen still afflicts a large
portion of the human population, developing methods to decrease Salmonella contamination in
poultry products would be beneficial for both the consumers and the poultry industry. This is
particularly important for the United States as there is an extensive poultry industry that
comprises multiple poultry integrators and growers, serving to provide a significant quantity of
poultry within the country and for export.
Rolling Circle Amplification (RCA) and its applications
Rolling circle amplification (RCA) is an isothermal enzymatic reaction that uses DNA
polymerase to produce a long single stranded DNA containing tandemly repeated sequences. A
primer is annealed to a circular single stranded DNA template and the polymerase with strong
strand-displacement activity continuously incorporate nucleotides to generate a long single
stranded DNA (Ali et al., 2014). The major components needed to produce RCA are DNA
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polymerase, primer, dNTPs and circular single stranded DNA template. The circular DNA
template can be synthesized enzymatically by ligation of single stranded linear DNA. Although
RCA is a simple isothermal process, it is becoming a powerful tool that is now used to produce
nanomaterials with various functional properties (Ali et al., 2014). Particularly, when it is
designed to contain DNA aptamer sequences, the resulting RCA products can display strong
affinity against the target molecules via hundreds of DNA aptamers (Al-Ogaili et al., 2020)
Due to its ability to produce a single stranded DNA consisting of the same DNA
sequences repeated thousands of times, and the simplicity of its reaction, RCA has been used in
several applications such as protein detection, stem cell fishing, nanomaterials fabrication, and
vaccine. In clinical practice, detection of protein plays an essential role and RCA has been used
as a platform for electrochemical detection for protein (Zhou et al., 2007). In this method,
immobilization of antibodies was done on electrode surface to capture protein target. The
detection was done by the deposition of silver enzymatically which was enabled by highly
efficient readout of the RCA. This readout by RCA is more efficient when compared with the
redox-labeled probe platform with low readout efficacy. Because aptamers are widely available
for many proteins, Zhou et al. (2007) concluded that this method is promising for ultrasensitive
immunoassay. Stem cell is another important topic in biology that has been widely studied
because of its importance in cell-based therapies (Yao et al., 2020). However, it is very difficult
to capture stem cells from bone marrow because of its ultra-low concentration. RCA has been
employed to effectively fish stem cell by using a double-RCA strategy that generates a physical
cross-link DNA (Yao et al., 2020). In this strategy, two different RCAs were produced
separately. RCA 1 contained aptamers that has high affinity for a specific membrane protein of
bone marrow mesenchymal stem cells (BMSCs). RCA 2 was designed to be partially
2

complementary with RCA 1, thereby forming a crosslink with RCA 1. RCA 2 was hybridized
with RCA 1 to form a cross-link of cell-anchored DNA. The stem cells once captured can be
released using DNase I digestion of the DNA network. According to Yao et al. (2020), this
method has been proven to be an effective way to capture stem cell amidst tens of thousands of
other cells. The stem cell that is released enzymatically still maintains normal cell activity.
DNA is also an excellent tool for the fabrication of nanomaterial (Baker et al., 2021).
There is limited chemistry to increase the functionality of this nanomaterial such as highperformance scaffold and DNA nanoflowers (DNFs). Baker et al. (2021) strategically used
orthogonal method to produce RCA and DNFs. The DNA and protein cargo were modified to
expand the chemical functionality of the system. This method has been used to produce DNFs
with multiple aptamers surfaces capable of binding to cancer cell. This DNA-based nanomaterial
is useful in the biomedical field for therapeutic and diagnostic purposed because of their high
target affinity and specificity.
The use of aptamer that has high affinity for CD40 has also been used to develop RCA that
was used as a vaccine adjuvant (Al-Ogaili et al., 2020). This was accomplished by first developing
DNA aptamer with affinity for chicken CD40 extra domain (chCD40ED). These aptamers were
tested and two were selected to make RCA containing aptamers with affinity for chCD40ED. The
aptamer RCA was conjugated with M2e epitope peptide of influenza virus and the complex was
injected into chicken. The result demonstrated that the RCA vaccine complex was able to stimulate
anti-M2e IgG antibody that is significantly higher than the control group (Al-Ogaili et al., 2020).
Enhancing vaccination efficacy via CD40 targeting
A method to enhance vaccine efficacy is to purposely engage and activate immune cells,
specifically the professional antigen-presenting cells which initiate the acquired immune
3

response. A common marker on these cells is the CD40 receptor, which is known for its ability
to stimulate dendritic cells, increase the pro-inflammatory activity of macrophages, and provoke
maturation of B-cells while inducing class-switching to more effective antibody isotypes.
Previous work on targeting CD40 using monoclonal antibody (mAb) against the chicken CD40
receptor (Chen et al., 2010) has produced a significant result. When this anti-CD40 mAb is
complexed with an antigen target (Figure 1) and used to immunize chickens, there was a
significantly more rapid and extensive target-specific antibody response within a week as
compared to immunization with the antigen alone (without the CD40 mAb) (Chen et al., 2012;
Chou et al., 2016; Vuong et al., 2017). This was attributed to the ability of the mAb to both
activate the antigen-presenting cell and also directly present the antigen to this cell to manipulate
downstream immune responses. This complex has been proven to provide protection against
disease when used as a vaccine, capable of protecting chickens against highly pathogenic avian
influenza (100% survival after H5N1 challenge), ameliorating the immunosuppressive effects of
infectious bursal disease, and decreasing enteric lesions associated with necrotic enteritis (Duff
et al., 2019; Vuong et al., 2018). Although this system is particularly effective as an adjuvant
(immunostimulator) and delivery vehicle for vaccination, the use of mAbs is very expensive for

Figure 1. Original monoclonal antibody (mAb) based CD40-targeting adjuvant system. A
central streptavidin is used as a central scaffold to complex biotinylated mAb and biotinylated
antigen.
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practical use in the poultry industry. Production of purified mAb is a very expensive and
laborious process. The original mAb-based CD40-targeting complex also required the use of
streptavidin protein as a central scaffold (able to bind 4 biotinylated proteins). This necessitated
that both the CD40-targeting mAb and the vaccine antigen target need to be biotinylated for the
separate vaccine components to be conjugated by the streptavidin to form a singular vaccine
complex (Figure 1). This preparation process is expensive, laborious, and prone to handler error.
To advance the CD40-targeting vaccine adjuvant system to a more accessible platform (poultry
vaccine costs average less than 1 cent per dose), the mAb needed to be replaced with a cheaper
and easier-to-produce component and the use of streptavidin as a scaffold needed to be
eliminated from the design. A bivalent design, which would permit both CD40 receptor
engagement/activation and single-step antigen loading (without the use of additional
supplementary scaffolding proteins), would make this vaccination system more accessible.
Aptamer RCA as a novel adjuvant to enhance vaccination efficacy
To overcome these limitations in the mAb-based CD40-targeting immunization platform,
aptamers were developed to replace the use of mAb. Aptamers are nucleotide-based (either DNA
or RNA) and can be easily developed and produced at a low cost. Because aptamers are nucleotidebased, the final sequence can be documented, products easily screened for quality assurance, and
can avoid master stock contamination issues. Aptamers have been successfully used as
immunostimulators in various immunizations (Wengerter et al., 2014). The anti-CD40 aptamers
screened and selected to replace the mAb were purposely constructed as a long chain of aptamers
using RCA to ensure proper engagement with the CD40 receptor on antigen-presenting cells.
When streptavidin was used as a central scaffold to complex the anti-CD40 aptamer RCA with a
model peptide antigen target (M2e peptide from avian influenza virus), immunized chickens were
5

confirmed to be equally immunogenic responsive as compared to the original mAb-based system
(Al-Ogaili et al., 2020). In this study, we aim to improve the adjuvant platform by eliminating the
streptavidin scaffold system and use the improved adjuvant system to develop vaccines to control
Salmonella in broiler chickens.
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MATERIALS AND METHODS
Oligonucleotides
All oligonucleotides used in this study shown in Table S1 were synthesized through
Integrated DNA Technology (IDT).
Aptamer binding assay
We obtained 3 Salmonella strains from the Poultry Health Laboratory (PHL) at the
University of Arkansas, Fayetteville: S. Typhimurium, S. Kentucky, and S. Enteriditis. All strains
were killed using formalin, when needed, and suspended in buffer. To quantify the binding
affinity of each aptamer to different strains of Salmonella, the cells of each strain (live or killed)
were washed three times, re-suspended in PBS with 10µM of FAM aptamer and incubated at
room temperature for 1 hour. After incubation, the mixture was centrifuge at 12,000 rpm for 15
minutes and cells were washed 3 times to remove fluorescence-labeled aptamer (FAM labeled at
5’ end; FAM aptamer) that was not bound to the cells. The washed cell-FAM aptamer pellet was
transferred to black colored 96-welled plates to measure fluorescence (excitation 485 nm:
emission, 528nm) using a microplate fluorescence reader (Park et al., 2014).
Design of the template for 3Sal-aptamer RCA
The sequences of 3 selected aptamers with a better binding affinity for Salmonella
serotypes were used to design linear template for the production of 3Sal-aptamer RCA. Reverse
complements of the 3 sequences were lined up side by side with spacer complementary to
aptamer RCA II to give a sequence from the 3′ to 5′ end as shown in Table 1. The different
colors show the sequences of the different aptamers used to design the template.
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Table 1. DNA sequences of the aptamers
Oligonucleotide

Sequence

33

5′-TATGGCGGCGTCACCCGACGGGGACTTGACATTATGACAG-3′

S8-7

5′-CTGATGTGTGGGTAGGTGTCGTTGATTTCTTCTGGTGGGG-3′

C4

5′-ACGGGCGTGGGGGCAATGCCTGCTTGTAGGCTTCCCCTGTGCGCG-3′

3Sal-aptamer

5′ –Phospho-AAGACGTTCCCGCGCACAGGGGAAGCCTACAAGCAGGCATTGCCCCCACGCCCGT

RCA template

GTCACCCCACCAGAAGAAATCAACGACACCTACCCACACATCAGGTCA
CTGTCATAATGTCAAGTCCCCGTCGGGTGACGCCGCCATATTCAGATGC -3′

3Sal-aptamer

5′ –GCATCTGAATATGGCGGCGTCACCCGACGGGGACTTGACATTATGACAG
TGACCTGATGTGTGGGTAGGTGTCGTTGATTTCTTCTGGTGGGGTGAC

RCA

ACGGGCGTGGGGGCAATGCCTGCTTGTAGGCTTCCCCTGTGCGCGGGAACGTCTT -3′

Rolling Circle Amplification
The production of rolling circle amplification (RCA) started with annealing.
Phosphorylated linear DNA template (25pmol = 10 µM, 2.5 µL) and biotinylated primer
(250pmol=100 µM, 2.5 µL) dissolved in TE buffer (45 µL) were mixed, denatured at 95°C for
10 min, and annealed at 56 °C for 5 min. To synthesize the circular template needed for RC
reaction, ligation of the naked template was done by mixing T4 DNA ligase (Cat# M0202S,
NEB, USA; 400 units/µL, 1 µL), 10 × T4 ligase reaction buffer (6 µL), and Milli-Q water (3 µL)
with the annealed product to make a total volume of 60 µL ligation system. The ligation reaction
was carried out at 16°C for 8h, and the enzyme was heat inactivated at 65°C for 10 min. The next
step was the RCA reaction which was done by hybridizing the ligated circular template with the
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primer (volume of 60 µL) was mixed with phi29 DNA polymerase (Cat# M0269L, NEB, USA;
10 units/µL, 2 μl), 10 × phi29 DNA polymerase reaction buffer (8 μl), 100 × bovine serum
albumin (BSA, 0.8 μl), and dNTPs (10 mM, 10 μl). RCA reaction was performed at 30ºC for 16
hrs. The size of the RCA products was characterized by 0.8% agarose gel electrophoresis which
was stained with gel red, and image was viewed using ultraviolet light. RCA products were 10x
diluted before running the electrophoreses.
Determination of Salmonella-loading capacity of aptamer DNA network complex.
Salmonella was cultured for 16 hours overnight in LB broth at 37˚C and washed 3 times
in PBS. The washed cells were diluted 2,000 times. Eighty µL of the diluted cell suspension was
transferred into two different 1.5ml microcentrifuge tubes (one for DNase I digestion and the
other for no-digestion control) and 10 µL Sal-aptamer RCA was added to each of the tubes and
incubated for 1 hour at room temperature with gentle shaking. An aliquot of the diluted
Salmonella cell suspension was 10X-diluted and plated on LB agar plates to determine CFUs/ml.
After an hour of incubation, 10 µL of aptamer RCA II was added to the mixture and incubated
for another one hour. Biotinylated magnetic beads were added to the mixture in both tubes after
incubation and the new mixture was incubated at room temperature for another one hour to
allow binding of the magnetic beads with the Salmonella-RCA network. Magnetic rack was
used to separate the Salmonella-RCA network that binds to the magnetic beads. The clear liquid
was pipette out and the cell network was re-constituted again. One thousand µL of PBS was used
to re-suspend the cell network and washed three times to ensure that unbound Salmonella was
washed out. Final re-suspension of Salmonella-RCA network was done in 99 µL of DNase 1
buffer, and 1 µL (0.1U) of DNase 1 was added to one tube for DNase I digestion, while 1µL of
sterile water was added to another tube (no-digestion control). The mixture was incubated for
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1hour at room temperature to ensure release of the cell from the network by the enzymatic
digestion of the DNA in tube one while tube two should remain undigested. Magnetic rack was
used to separate the magnetic beads from the released cell. The supernatant was pipette out and
10x serial dilution of the supernatant was done, plated, and incubated at 37˚C for 24 hours. The
colonies were enumerated to calculate the number of Salmonella cells loaded to SalmonellaRCA network.
Formation of RCA network complex through hybridization of two RCA products.
We performed hybridization between the following 3 pairs of RCA products and the
progress in hybridization was monitored at 0 hour and 1 hour: (1) 3Sal-aptamer RCA and
aptamer RCA II, (2) 3Sal-aptamer RCA and 3Sal-aptamer RCA, and (3) aptamer RCA II and
aptamer RCA II. Briefly 3Sal-aptamer RCA was stained with Gel-red in a microcentrifuge tube
and another 3Sal-aptamer RCA in a separate microcentrifuge tube with Gel-green. Aptamer
RCA II was also stained with Gel-red and Gel-green separately. The reaction was set up as
follows; 100µL of 3Sal-aptamer RCA stained with Gel-green was pipetted into a 1.5 ml tube and
100µL of aptamer RCA II stained with Gel-red was added. The second reaction was done by
adding 3Sal-aptamer RCA stained with Gel-red and Gel-green together in a tube, while the third
reaction was adding the aptamer RCA II that was stained with gel red and SYBR green together
in a tube. The three reactions were viewed using ultraviolet light to see the physical interaction at
0 hour. The mixtures were incubated at room temperature with minimum shaking for 1 hour and
monitored using ultraviolet light.
Preparation and evaluation of the aptamer RCA network complex
Killed S. Typhimurium was washed three times using PBS and finally re-suspended in
PBS. It was then diluted 2000x to achieve a cell density of 2.15 × 106 CFUs. This cell
10

concentration was confirmed using the hemocytometer. 80µL of the diluted cell was pipette into
a 1.5 ml microfuge tube each and 10µL of 3Sal-aptamer RCA was added to the tube. The
mixture was incubated at room temperature for one hour with minimum shaking. After an hour,
10µL of aptamer-RCA II was added to the tube and incubated at room temperature for another
one hour with minimum shaking to envelop the RCA-Salmonella network. Biotinylated
streptavidin beads were added to the mixture to capture RCA-Salmonella complex. This was
done by incubating the mixture for another one-hour after which a magnetic rack was used to
remove the unbound Salmonella and the complex was washed three times and later resuspended
in PBS.
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RESULTS AND DISCUSSION
Comparison of the binding of Salmonella-specific aptamers against live vs dead cells
One question we wanted to ask was if aptamer binding to Salmonella cells would be the
altered between the live and killed cells of Salmonella. It was due to the fact the use of live cells
is more convenient and straightforward to perform the analyses related to binding of aptamers or
RCA containing aptamers, while the final preparation of the finished Salmonella-RCA network
complex for evaluation in chickens needed to be done using killed cells. Therefore, we
performed the aptamer binding assay using 3 DNA aptamers (ST2P, SAL26, and ST1) against
the live and killed cells for each of the 5 strains (S. Typhimurium, S. Enteritidis, S. Heidelberg, S.
Kentucky, and E. coli). The results of the binding assay shown in Figure 2 shows that aptamer
binding is not different between the live and dead cells except for S. Kentucky.
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Figure 2. Binding affinity of 6-FAM aptamers for
live and dead cells of different Salmonella
serotypes and E. coli
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Evaluation and selection of the Salmonella-specific aptamers
To produce RCA product with a good binding affinity to broad range of Salmonella
serotypes, 6 DNA aptamers with binding capacity to different serovars of Salmonella were
searched and selected from the published research (Table S1). We performed the assays to
compare the binding affinity of these 6 aptamers against 3 serotypes of Salmonella strains (S.
Typhimuirum, S. Enteritidis, and S. Kentucky). As shown in Figure 3, the result of the assay
showed that the aptamer C4 has the highest binding affinity to all three Salmonella serotypes
among all 6 aptamers evaluated. The aptamer ST2P on the other hand showed the least binding
affinity of all aptamers evaluated. The 3 aptamers with higher binding affinity to Salmonella
serotypes were selected (S8-7, 33 and C4) and used to design template for generating
Salmonella-specific RCA product.

14

Figure 3. Binding affinity of 6 FAM-aptamers for S.
Typhimurium, S. Enteriditis, S. Kentucky
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Rolling Circle Amplification
The designed template for Salmonella RCA was used to produce the RCA and the RCA
products were analyzed using 0.8% agarose gel electrophoreses. The RCA product was 10x
diluted and loaded to run the agarose gel electrophorese to enable better visualization of the
result. The result in Figure 4 shows the RCA products of high molecular weight with strong
intensity, which suggests successful production of RCA products.
1.
2.
3.
4.
5.
6.
7.
8.
9.

3Sal-aptamer RCA
3Sal-aptamer RCA template
Primer for 3Sal-aptamer RCA
Aptamer RCA II
Aptamer RCA II template
Primer for aptamer RCA II
Aptamer NC-RCA
Aptamer NC-RCA template
2-Log ladder

Figure 4. Analysis of the RCA products using agarose gel electrophoresis

Production and evaluation of the Salmonella-RCA complex network
The two RCA products (3Sal-aptamer RCA and aptamer RCA II) were designed to
hybridize to each other partially through interaction between the two complementary spacer
regions as illustrated in Figure 5. To confirm this cross-linking process, we used two different
DNA staining dyes with different colors (Gel-Red and Gel-Green). The result in Figure 6
showed that 3Sal-aptamer RCA and aptamer RCA II were able to bind well as evidenced by the
colors changed from red and green to yellow upon mixing. On the other hand, the mixing of the
same kind of RCA products (either 3Sal-aptamer RCA or aptamer RCA II) stained with red and
green colors did not result in the change of the colors to yellow, suggesting separation of the two
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RCA products even after 1 hour of mixing. Based on the result from this assay, we conclude that
the design of our RCA products allowed cross-linking between the two RCA products through
efficient hybridization between the two RCA products.

Figure 5. Design of the spacer regions of the two RCA products (3Sal-aptamer RCA and
aptamer RCA II) to facilitate hybridization between the two spacer regions. (A) the 19nt
sequences of the two spacer regions and (B) the diagram illustrating the cross-linking of
the two RCA products through hybridization of the spacer regions.

Figure 6. Interaction between the RCA products with the same or
complementary spacer regions.
17

We also wanted to quantify the number of S. Typhimurium cells that can be loaded into
the RCA network complex. For this purpose, we used DNA I enzyme to digest DNA network
complex (3Sal-aptamer RCA + S. Typhimurium + aptamer RCA II), thereby releasing the
captured S. Typhimurium cells as previous described by Yao et al. (2020). The same assay was
performed, yet without DNase I digestion as a control group. The result in Figure 7 shows that
the strategy of using DNase I to release the captured S. Typhimurium cells was effective, and the
count of S. Typhimurium cells were consistently and significantly higher with DNase I digestion
as compared to the no-digestion control group. From this data, we were able to estimate the
number of S. Typhimurium cells captured in the RCA network complex to be on average
2.15 × 106 CFUs of S. Typhimurium cells per 1 ml of RCA network complex by subtracting the
count of the no-digestion control group from the number from DNase I digestion group.

Figure 7. Estimation of the number of S. Typhimurium cells loaded to Salmonella-RCA
network using DNase I digestion to release S. Typhimurium cells captured in RCA
network
18

CONCLUSIONS
In the current study, we attempted to develop a novel RCA network complex as a vaccine
candidate to control Salmonella serotypes in broiler chickens. This RCA network complex
consists of two RCA products with specific binding affinity against various serotypes of
Salmonella (3Sal-aptamer RCA) and CD40 receptor (aptamer RCA II). We produced this
complex and demonstrated S. Typhimurium cells can be securely loaded within the complex. In
the next step of this project, we will evaluate the efficacy of this novel RCA network complex
loaded with Salmonella as a novel vaccine to control Salmonella in broiler chickens.
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SUPPLEMENTARY MATERIALS
Table S1. DNA sequences of the aptamers used in this study.
Name
ST1

DNA Sequence (5’ → 3’)
6FAM-CCGATGTCCGTTAGGGCTCCTCCATAGAT

References
Park et al.,
2014; Silva
et al.
Lavu et al.,
2016

SAL26

6FAMTAGCTCACTCATTAGGCACATTTGTGGCACCAAATTTGAATTAATC
AAGACAGTGTGGTGCATAGTTAAGCCAGCC

ST2P

6FAMATAGGAGTCACGACGACCAGAAAGTAATGCCCGGTAGTTATTCAAA
GATGAGTAGGAAAAGATATGTGCGTCTACCTCTTGACTAAT

Duan et al.,
2013

33

6FAM-TATGGCGGCGTCACCCGACGGGGACTTGACATTATGACAG

Joshi et al.,
2009

S8-7

6FAM-CTGATGTGTGGGTAGGTGTCGTTGATTTCTTCTGGTGGGG

Dwivedi et
al., 2013

C4

6FAMACGGGCGTGGGGGCAATGCCTGCTTGTAGGCTTCCCCTGTGCGCG

Moon et al.,
2013

SEQ3
(Illumina)

CCGAATTCGAAGGACAAGAGGTGGAATTGGTAATGGGGTGTAAATG
GAGCAGTGAATTCGTCTTTTATGCTACGTCCCGC

SEQ4
(Illumina)

CCGAATTCGAAGGACAAGAGTAGGGCTACATGGAATAGGGATCAGAA
GAGCAGGGCTAGGTCTTTTATGCTACGTCCCGC

Aptamer
RCA II
template
3Sal
aptamer
RCA
template
B-primer

Primer
with no
Biotin

GCATCTGAAGCGGACGTAGCATAAAAGACGAATTCACTGCTCCATT
TACACCCCATTACCAATTCCACCTCTTGTCCTTCGAATTCGGGATC
CACCGTAGCAGCGGGACGTAGCATAAAGACCTAGCCCTGCTCTTCT
GATCCCTATTCCATGTAGCCCTACTCTTGTCCTTCGAATTCGGGGA
ACGTCTT
PhosphoAAGACGTTCCCGCGCACAGGGGAAGCCTACAAGCAGGCATTGCCCC
CACGCCCGTGTCACCCCACCAGAAGAAATCAACGACACCTACCCAC
ACATCAGGTCACTGTCATAATGTCAAGTCCCCGTCGGGTGACGCCG
CCATATTCAGATGC
Biotin-GGGAACGTCTTGCATCTGAA

GGGAACGTCTTGCATCTGAA
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